Gilla Kaplan - Net Worth and Insider Trading
Gilla Kaplan Net Worth
The estimated net worth of Gilla Kaplan is at least $8 Million dollars as of 2024-11-10. Gilla Kaplan is the Director of Celgene Corp and owns about 76,301 shares of Celgene Corp (CELG) stock worth over $8 Million. Details can be seen in Gilla Kaplan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gilla Kaplan has not made any transactions after 2018-05-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gilla Kaplan
Gilla Kaplan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gilla Kaplan owns 2 companies in total, including Avalo Therapeutics Inc (AVTX) , and Tyra Biosciences Inc (TYRA) .
Click here to see the complete history of Gilla Kaplan’s form 4 insider trades.
Insider Ownership Summary of Gilla Kaplan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2021-12-31 | director |
| TYRA | Tyra Biosciences Inc | 2021-09-14 | director |
Gilla Kaplan Latest Holdings Summary
Gilla Kaplan currently owns a total of 1 stock. Gilla Kaplan owns 76,301 shares of Celgene Corp (CELG) as of May 18, 2018, with a value of $8 Million.
Latest Holdings of Gilla Kaplan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CELG | Celgene Corp | 2018-05-18 | 76,301 | 108.24 | 8,258,820 |
Holding Weightings of Gilla Kaplan
Gilla Kaplan Form 4 Trading Tracker
According to the SEC Form 4 filings, Gilla Kaplan has made a total of 0 transactions in Celgene Corp (CELG) over the past 5 years. The most-recent trade in Celgene Corp is the sale of 27,750 shares on May 18, 2018, which brought Gilla Kaplan around $2 Million.
Insider Trading History of Gilla Kaplan
- 1
Gilla Kaplan Trading Performance
Gilla Kaplan Ownership Network
Ownership Network List of Gilla Kaplan
Ownership Network Relation of Gilla Kaplan
Gilla Kaplan Owned Company Details
What does Avalo Therapeutics Inc do?
Who are the key executives at Avalo Therapeutics Inc?
Gilla Kaplan is the director of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .
Avalo Therapeutics Inc (AVTX) Insider Trades Summary
Over the past 18 months, Gilla Kaplan made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 74,840 shares made by Caissa Capital Management Ltd. , a net sale of 3,683,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 4,000 shares made by Garry Arthur Neil .
In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 331 shares were bought by its insiders, resulting in a net sale of 15,017 shares.
Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avalo Therapeutics Inc Insider Transactions
Gilla Kaplan Mailing Address
Above is the net worth, insider trading, and ownership report for Gilla Kaplan. You might contact Gilla Kaplan via mailing address: C/o Celgene Corporation, 86 Morris Avenue, Summit Nj 07901.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
